Health Care · Services-Misc Health & Allied Services, NEC · Nasdaq · CIK 1551306 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $31.37Day +1.98%Mkt cap $2.5BP/E (FY) 48.3×1Y +37.4%Off 52W high −5.1%Vol (1Y) 55.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,692 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Price impliesNEVER-OBSERVED · 41.6% growth |
| Short interest5.9% of sh out |
| Days to cover3.7d |
| 13F net flow (QoQ)+1.51% |
| Top-10 13F concentration53.0% |
| Next report (est.)2026-08-06 |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)48.3× |
| Sales (TTM)$1.29B |
| Earnings (TTM)$67.7M |
| ROE12.5% |
| Net margin4.5% |
| ROIC15.8% |
| YTD+22.2% |
| 1Y+37.4% |
| 3Y−24.9% |
| 5Y−43.5% |
| Since incept. (ann.)+10.5% |
Total return through 2026-07-29 · series begins 2019-10-25. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)55.7% |
| Ann. volatility (3Y)52.4% |
| Sharpe (1Y)0.82 |
| Sharpe (3Y)0.11 |
| Max drawdown (1Y)−42.6% |
| Max drawdown (3Y)−68.1% |
| Beta (3Y vs SPY)0.87 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 12.0M | $204M | 15.32% | −7.4% |
| FMR LLC | 6.5M | $110M | 8.30% | −1.0% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.3M | $90M | 6.76% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.5M | $59M | 4.44% | new |
| STATE STREET CORP | 3.1M | $52M | 3.93% | +4.3% |
| AMERIPRISE FINANCIAL INC | 2.8M | $48M | 3.61% | +24.0% |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 2.7M | $46M | 3.44% | +46.9% |
| MORGAN STANLEY | 2.3M | $39M | 2.92% | +77.8% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 102.4% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 6,307,052 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | $0.29 | +70.6% | $328.5M | +1.4% |
| 2025-12-31 | 2026-02-26 | — | — | $318.4M | +6.7% |
| 2025-09-30 | 2025-11-06 | $0.15 | +36.4% | $313.3M | +9.3% |
| 2025-06-30 | 2025-08-07 | $0.19 | +11.8% | $332.9M | +9.5% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Reportable 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
| Sales growth 3Y17.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
